Published: 17 September 2018
Author(s): Krunalkumar Patel, Rajkumar Doshi, Dean Decter, Jay Shah, Perwaiz Meraj
Section: Letter to the Editor

The treatment of chronic total occlusion (CTO) of coronary arteries is a challenge for physicians. In recent years, CTO treatment with percutaneous coronary intervention (PCI) has increased with procedural success rates as high as 70% [1]. However, CTO-PCI treatment is questionable as a recent presentation of the DECISION-CTO trial demonstrated no clinical outcome benefit over maximum medical therapy. In contrast, the EURO-CTO trail demonstrated improved health status and functional class as compared to medical management.

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.